FAIRFIELD, Conn., July 1, 2009 (GLOBE NEWSWIRE) -- Competitive Technologies, Inc. (NYSE Amex:CTT) offers a non-invasive pain therapy without the harmful side effects of narcotic painkillers. Cleared for use in the U.S. by the Food and Drug Administration (FDA), the device offers a non-invasive method without harmful side effects for rapid treatment of high-intensity oncologic and neuropathic pain, including pain resistant to morphine and other drugs. CTT’s pain therapy also has Medical Device CE certification from the European Union.
